Viewing Study NCT06748495


Ignite Creation Date: 2025-12-24 @ 1:21 PM
Ignite Modification Date: 2025-12-28 @ 12:24 PM
Study NCT ID: NCT06748495
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-27
First Post: 2024-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Sponsor: Hunan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module